These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2855896)

  • 21. [Occurrence of chronic granulomatous disease must be surveyed--new treatment exists].
    Palmblad J; Gyllenhammar H; Ringertz B; Elinder G; Lidefelt KJ; Ahlin A; Smith E; Hammarström L
    Lakartidningen; 1991 Feb; 88(7):508-9, 511. PubMed ID: 1900341
    [No Abstract]   [Full Text] [Related]  

  • 22. [Molecular basis of chronic granulomatous disease].
    Zekanowski C; Skopczyńska H
    Postepy Biochem; 1998; 44(3):193-200. PubMed ID: 10022037
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular genetic analysis of phagocyte oxidase cytochrome b558 mutations leading to chronic granulomatous disease.
    Hossle JP; Berthet F; Erny C; Seger RA
    Immunodeficiency; 1993; 4(1-4):303-6. PubMed ID: 8167722
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biological properties and clinical applications of interferon gamma (IFN-gamma)].
    Robak T
    Acta Haematol Pol; 1994; 25(1):19-29. PubMed ID: 8209610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficient flavoprotein component of the NADPH-dependent O2-.-generating oxidase in the neutrophils from three male patients with chronic granulomatous disease.
    Gabig TG; Lefker BA
    J Clin Invest; 1984 Mar; 73(3):701-5. PubMed ID: 6707199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
    Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
    Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [NADPH oxidase complex of phagocytic cells and molecular basis of genetic deficiency in their bactericidal activity].
    Bejaoui M; Dellagi K
    Arch Inst Pasteur Tunis; 1991; 68(3-4):237-42. PubMed ID: 1824504
    [No Abstract]   [Full Text] [Related]  

  • 29. Absence of both subunits of cytochrome b558 in the UM384 cell line relative to the inability to generate superoxide anions.
    Champelovier P; Laporte F; Verhoeven AJ; Hilarius P; de Klein A; Revol C; Seigneurin D; Kolodie L
    Exp Hematol; 1993 Jul; 21(7):885-92. PubMed ID: 8391470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.
    Murray HW; Rubin BY; Carriero SM; Harris AM; Jaffee EA
    J Immunol; 1985 Mar; 134(3):1982-8. PubMed ID: 2981929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic granulomatous disease of childhood: differential diagnosis and prognosis.
    Grumach AS; Bellinai-Pires R; Araujo IS; Gonzalez CH; Carneiro-Sampaio MM
    Rev Paul Med; 1993; 111(6):472-6. PubMed ID: 8052796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simultaneous flow cytometric measurement of neutrophil phagocytosis and oxidative burst in whole blood.
    Trinkle LS; Wellhausen SR; McLeish KR
    Diagn Clin Immunol; 1987; 5(2):62-8. PubMed ID: 3621481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell.
    Ezekowitz RA; Sieff CA; Dinauer MC; Nathan DG; Orkin SH; Newburger PE
    Blood; 1990 Dec; 76(12):2443-8. PubMed ID: 2176110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and visualization of oxidase activity in phagocytes.
    Hallett MB; Cole C; Dewitt S
    Methods Mol Biol; 2003; 225():61-7. PubMed ID: 12769474
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature.
    Leung T; Chik K; Li C; Shing M; Yuen P
    Bone Marrow Transplant; 1999 Sep; 24(5):567-70. PubMed ID: 10482944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A simple method for measuring two function parameters of phagocytizing cells using immunobeads].
    Jacobi HD; Sokolowska-Köhler W; Zietlow C
    Z Med Lab Diagn; 1990; 31(6):351-2. PubMed ID: 2281718
    [No Abstract]   [Full Text] [Related]  

  • 37. Leukocyte transfusions in chronic granulomatous disease: persistence of transfused leukocytes in sputum.
    Buescher ES; Gallin JI
    N Engl J Med; 1982 Sep; 307(13):800-3. PubMed ID: 7110245
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease.
    International Chronic Granulomatous Disease Cooperative Study Group
    N Engl J Med; 1991 Feb; 324(8):509-16. PubMed ID: 1846940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbicidal mechanisms of phagocytes.
    Gabay JE
    Curr Opin Immunol; 1988; 1(1):36-40. PubMed ID: 2855829
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chronic granulomatous disease. A disease model with new therapeutic possibilities].
    Lappegård KT
    Tidsskr Nor Laegeforen; 1989 Sep; 109(25):2554-6. PubMed ID: 2814975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.